MICHAEL WHITE to Cytoreduction Surgical Procedures
This is a "connection" page, showing publications MICHAEL WHITE has written about Cytoreduction Surgical Procedures.
Connection Strength
3.470
-
Long-Term Cytoreduction Outcomes With or Without Heated Intraperitoneal Chemotherapy For Colorectal Peritoneal Metastases. J Am Coll Surg. 2025 Jul 01; 241(1):28-37.
Score: 0.944
-
Incomplete Cytoreduction and Need for Major Hepatectomy Predict Shorter Survival in Patients Undergoing Combined Cytoreductive Surgery and Hepatectomy for Metastatic Colorectal Cancer. Ann Surg Oncol. 2024 Oct; 31(10):6366-6368.
Score: 0.884
-
Stapled Versus Hand-Sewn Anastomosis in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. J Gastrointest Surg. 2022 11; 26(11):2365-2367.
Score: 0.766
-
Utility of Circulating Tumor DNA in Appendiceal Tumors. J Gastrointest Surg. 2023 12; 27(12):3071-3073.
Score: 0.209
-
Treatment Variation and Long-Term Outcomes of Low-Grade Appendiceal Neoplasms. Ann Surg Oncol. 2023 Dec; 30(13):8138-8143.
Score: 0.209
-
Oncologic Components of HIPEC: Key Question : In patients with gastric or colorectal adenocarcinoma metastatic to the peritoneum, does cytoreductive surgery (CRS) plus hyperthermic intraperitoneal perfusion with chemotherapy (HIPEC) prolong survival or increase the risk of complications relative to CRS alone? Ann Surg Oncol. 2022 10; 29(11):6561-6564.
Score: 0.186
-
Factors Associated with Resection and Survival After Laparoscopic HIPEC for Peritoneal Gastric Cancer Metastasis. Ann Surg Oncol. 2020 Dec; 27(13):4963-4969.
Score: 0.168
-
Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit. Ann Surg Oncol. 2024 Jan; 31(1):614-621.
Score: 0.053
-
Decreasing Environmental Operating Room Chemotherapy Levels Following Heated Intraperitoneal Chemotherapy (HIPEC) Through Implementation of Standard Protocols. Ann Surg Oncol. 2023 11; 30(12):6981-6982.
Score: 0.052